# Umberto Cillo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/umberto-cillo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,035 |
| Field | Organ Transplantation Techniques and Outcomes |
| h-index | 72 |
| i10-index | 374 |
| Last Known Institution | University of Padua |
| OpenAlex ID | https://openalex.org/A5021781945 |
| ORCID iD | https://orcid.org/0000-0002-2310-0245 |
| Works | 1,053 |

## Researcher papers

- [Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis](https://scholariq.org/papers/predicting-survival-after-liver-transplantation-in-patients-with-hepatocellular/)
- [Prospective validation of the Barcelona Clinic Liver Cancer staging system](https://scholariq.org/papers/prospective-validation-of-the-barcelona-clinic-liver-cancer-staging-system/)
- [Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma](https://scholariq.org/papers/sirolimus-use-in-liver-transplant-recipients-with-hepatocellular-carcinoma/)
- [Surgery for cholangiocarcinoma](https://scholariq.org/papers/surgery-for-cholangiocarcinoma/)
- [Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features](https://scholariq.org/papers/renal-failure-and-bacterial-infections-in-patients-with-cirrhosis-epidemiology/)
- [Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma](https://scholariq.org/papers/liver-transplantation-for-the-treatment-of-moderately-or-well-differentiated/)
- [The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial](https://scholariq.org/papers/the-empirical-antibiotic-treatment-of-nosocomial-spontaneous-bacterial/)
- [The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?](https://scholariq.org/papers/the-critical-issue-of-hepatocellular-carcinoma-prognostic-classification-which/)
- [Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept](https://scholariq.org/papers/personalised-management-of-patients-with-hepatocellular-carcinoma-a/)
- [A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma](https://scholariq.org/papers/a-prospective-randomised-open-labeled-trial-comparing-sirolimus-containing/)
- [Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study](https://scholariq.org/papers/barcelona-clinic-liver-cancer-staging-and-transplant-survival-benefit-for/)

## Researcher topics

- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Researcher university

- [University of Padua](https://scholariq.org/institutions/university-of-padua/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.